Drug boosts long

Yahoo NewsDrug boosts long-term survival after breast cancer: studyYahoo NewsAfter 10 years, 93.5 percent of women in the anastrazole group were living breast cancer-free, compared to 89.2 percent in the tamoxifen group, according to the first major study to compare the two treatments, released at the American Society of ...Combo therapies effective in forms of leukemia, lymphoma and breast cancerWashington PostPfizer's Ibrance drug slows progression of breast cancerReutersStudy finds safer drug to prevent return of breast cancerPittsburgh Post-GazetteNewsmax -U.S. News & World Reportall 57 news articles »

Share this post